Mesenchymal stem cell transplantation to the mouse cochlea as a treatment for childhood sensorineural hearing loss

International Journal of Pediatric Otorhinolaryngology

Volumn 77, Issue 6, 2013, Pages 936-942

  Kasagi, Hiromi ^a   Kuhara, Takatoshi ^a   Okada, Hiroko ^a   Sueyoshi, Noriyoshi ^a   Kurihara, Hidetake ^a  

^a JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cochlea; Connexin26; Connexin30; Fibronectin; Mesenchymal stem cell; Sensorineural hearing loss

Indexed keywords

CONNEXIN 26; ENHANCED GREEN FLUORESCENT PROTEIN; FIBRONECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL STRUCTURE; COCHLEA; CONTROLLED STUDY; DISEASE COURSE; HEARING; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PERCEPTION DEAFNESS; PRIORITY JOURNAL; RETROVIRUS; SEMICIRCULAR CANAL;

AGE FACTORS; ANIMALS; CHILD; COCHLEA; DISEASE MODELS, ANIMAL; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GRAFT REJECTION; GRAFT SURVIVAL; HEARING LOSS, SENSORINEURAL; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MICE, INBRED C57BL; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84877822566     PISSN: 01655876     EISSN: 18728464     Source Type: Journal    
DOI: 10.1016/j.ijporl.2013.03.011     Document Type: Article

References (36)

1. Van Laer L., McGuirt W.T., Yang T., Smith R.J., Van Camp G. Autosomal dominant nonsyndromic hearing impairment. Am. J. Med. Genet. 1999, 89:167-174.
2. Op de Beeck K., Schacht J., Van Camp G. Apoptosis in acquired and genetic hearing impairment: the programmed death of the hair cell. Hear. Res. 2001, 281:18-27.
3. Wollert K.C., Meyer G.P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., et al. Intracoronary autologous bone-marrow cell transfer after myocardial infarction:the BOOST randomised controlled clinical trial. Lancet 2004, 364:141-148.
4. Giordano A., Galderisi U., Marino I.R. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J. Cell. Physiol. 2007, 211:27-35.
5. Devine S.M. Mesenchymal stem cells: will they have a role in the clinic?. J. Cell. Biochem. Suppl. 2002, 38:73-79.
6. Karussis D., Karageorgiou C., Vaknin-Dembinsky A., Gowda-Kurkalli B., Gomori J.M., Kassis I., et al. Safety and immunological effects of mesenchymal stem cell transplantation in patients with multiple sclerosis and amyotrophic lateral sclerosis. Arch. Neurol. 2010, 67:1187-1194.
7. Uccelli A., Laroni A., Freedman M.S. Mesenchymal stem cells for the treatment of multiple sclerosis and other neurological diseases. Lancet Neurol. 2011, 10:649-656.
8. Horwitz E.M., Prockop D.J., Fitzpatrick L.A., Koo W.W., Gordon P.L., Neel M., et al. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. 1999, 5:309-313.
9. Spicer S.S., Schulte B.A. Differentiation of inner ear fibrocytes according to their ion transport related activity. Hear. Res. 1991, 56:53-64.
10. Kikuchi T., Kimura R.S., Paul D.L., Adams J.C. Gap junctions in the rat cochlea: immunohistochemical and ultrastructural analysis. Anat. Embryol. (Berl.) 1995, 191:101-118.
11. Adams J.C. Immunocytochemical traits of type IV fibrocytes and their possible relations to cochlear function and pathology. J. Assoc. Res. Otolaryngol. 2009, 10:369-382.
12. Harigaya K., Cronkite E.P., Miller M.E., Shadduck R.K. Murine bone marrow cell line producing colony-stimulating factor. Proc. Natl. Acad. Sci. U.S.A. 1981, 78:6963-6966.
13. Umezawa A., Tachibana K., Harigaya K., Kusakari S., Kato S., Watanabe Y., et al. Colony-stimulating factor 1 expression is down-regulated during the adipocyte differentiation of H-1/A marrow stromal cells and induced by cachectin/tumor necrosis factor. Mol. Cell. Biol. 1991, 11:920-927.
14. Kamiya K., Fujinami Y., Hoya N., Okamoto Y., Kouike H., Komatsuzaki R., et al. Mesenchymal stem cell transplantation accelerates hearing recovery through the repair of injured cochlear fibrocytes. Am. J. Pathol. 2007, 171:214-226.
15. Singh P., Carraher C., Schwarzbauer J.E. Assembly of fibronectin extracellular matrix. Annu. Rev. Cell Dev. Biol. 2010, 26:397-419.
16. Liu Y.P., Zhao H.B. Cellular characterization of Connexin26 and Connnexin30 expression in the cochlear lateral wall. Cell Tissue Res. 2008, 333:395-403.
17. Shiga A., Nakagawa T., Nakayama M., Endo T., Iguchi F., Kim T.S., et al. Aging effects on vestibulo-ocular responses in C57BL/6 mice: comparison with alteration in auditory function. Audiol. Neurootol. 2005, 10:97-104.
18. Pankov R., Yamada K.M. Fibronectin at a glance. J. Cell Sci. 2002, 115:3861-3863.
19. Hynes R.O. Fibronectin 1990, Springer-Verlag, New York.
20. Kikuchi T., Adams J.C., Miyabe Y., So E., Kobayashi T. Potassium ion recycling pathway via gap junction systems in the mammalian cochlea and its interruption in hereditary nonsyndromic deafness. Med. Electron Microsc. 2000, 33:51-56.
21. Hequembourg S., Liberman M.C. Spiral ligament pathology: a major aspect of age-related cochlear degeneration in C57BL/6 mice. J. Assoc. Res. Otolaryngol. 2001, 2:118-129.
22. Ichimiya I., Suzuki M., Mogi G. Age-related changes in the murine cochlear lateral wall. Hear. Res. 2000, 139:116-122.
23. Ison J.R., Allen P.D., O'Neill W.E. Age-related hearing loss in C57BL/6J mice has both frequency-specific and non-frequency-specific components that produce a hyperacusis-like exaggeration of the acoustic startle reflex. J. Assoc. Res. Otolaryngol. 2007, 8:539-550.
24. Tasaki I., Fernandez C. Modification of cochlear microphonics and action potentials by KC1 solution and by direct currents. J. Neurophysiol. 1952, 15:497-512.
25. Nuttall A.L., LaRouere M.J., Lawrence M. Acute perilymphatic perfusion of the guinea pig cochlea. Hear. Res. 1982, 6:207-221.
26. Kada S., Nakagawa T., Ito J. A mouse model for degeneration of the spiral ligament. J. Assoc. Res. Otolaryngol. 2009, 10:161-172.
27. Beyer Nardi N., da Silva Meirelles L. Mesenchymal stem cells: isolation, in vitro expansion and characterization. Handb. Exp. Pharmacol. 2006, 174:249-282.
28. Schimmang T. Transcription factors that control inner ear development and their potential for transdifferentiation and reprogramming. Hear. Res. 2012, 2012.11.001 E-pub.
29. Zhao H.B., Kikuchi T., Ngezahayo A., White T.W. Gap junctions and cochlear homeostasis. J. Membr. Biol. 2006, 209:177-186.
30. Spicer S.S., Schulte B.A. Evidence for a medial K+ recycling pathway from inner hair cells. Hear. Res. 1998, 118:1-12.
31. Zdebik A.A., Wangemann P., Jentsch T.J. Potassium ion movement in the inner ear: insights from genetic disease and mouse models. Physiology (Bethesda) 2009, 24:307-316.
32. Monzack E.L., Cunningham L.L. Lead roles for supporting actors: Critical functions of inner ear supporting cells. Hear. Res. 2013, 2013.01.008 [E-pub].
33. Pieraggi M.T., Julian M., Bouissou H., Stocker S., Grimaud J.A. Dermal aging, Immunofluorescence study of collagens I and III and fibronectin. Ann. Pathol. 1984, 4:185-194.
34. Keithley E.M., Ryan A.F., Woolf N.K. Fibronectin-like immunoreactivity of the basilar membrane of young and aged rats. J. Comp. Neurol. 1993, 327:612-617.
35. Kelsell D.P., Dunlop J., Stevens H.P., Lench N.J., Liang J.N., Parry G., et al. Connexin 26 mutations in hereditary non-syndromic sensorineural deafness. Nature 1997, 387:80-83.
36. Kusunoki T., Cureoglu S., Schachern P.A., Baba K., Kariya S., Paparella M.M., et al. Age-related histopathologic changes in the human cochlea: a temporal bone study. Otolaryngol. Head Neck Surg. 2004, 131:897-903.